|
Volumn 94, Issue 4, 2002, Pages 1142-1150
|
Outpatient cancer drug costs: Changes, drivers, and the future
|
Author keywords
Delivery of health care; Drug costs; Health care costs; Managed care programs; Neoplasms; Physician's practice patterns
|
Indexed keywords
ANALGESIC AGENT;
ANTIBIOTIC AGENT;
ANTIDEPRESSANT AGENT;
ANTIEMETIC AGENT;
ANTIINFECTIVE AGENT;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
COLONY STIMULATING FACTOR;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
ERYTHROPOIETIN;
ETOPOSIDE;
FLUTAMIDE;
GASTROINTESTINAL AGENT;
GEMCITABINE;
GOSERELIN;
HEMOPOIETIC GROWTH FACTOR;
IRINOTECAN;
METHOTREXATE;
MITOMYCIN;
NARCOTIC AGENT;
NAVELBINE;
PACLITAXEL;
PROTECTIVE AGENT;
PROTON PUMP INHIBITOR;
TAXANE DERIVATIVE;
TOPOTECAN;
UNINDEXED DRUG;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
CANCER;
CANCER CHEMOTHERAPY;
CHILD;
COLORECTAL CANCER;
DRUG COST;
FEMALE;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HUMAN;
INFANT;
INJECTION;
LUNG CANCER;
MAJOR CLINICAL STUDY;
MALE;
MANAGED CARE;
MEDICAL PRACTICE;
MEDICARE;
OUTPATIENT CARE;
PHARMACY;
PRIORITY JOURNAL;
PROSTATE CANCER;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CHILD;
CHILD, PRESCHOOL;
COSTS AND COST ANALYSIS;
DRUG COSTS;
FEMALE;
HEALTH EXPENDITURES;
HEALTH MAINTENANCE ORGANIZATIONS;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
MIDDLE AGED;
NEOPLASMS;
OUTPATIENTS;
PRESCRIPTIONS, DRUG;
RETROSPECTIVE STUDIES;
|
EID: 0037083617
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.10347 Document Type: Article |
Times cited : (19)
|
References (34)
|